Cell lines

#Cell line development #Cell lines #Drug discovery #Interview

Addressing the growing demand for new treatments with cell lines

Dr James Taylor, Senior Scientist in Cell Line Development at Samsung Biologics, speaks with DDW’s Megan Thomas about how to address the challenges in meeting complex molecule requirements, regulatory standards, and environmental sustainability. Benefits for developers  The biopharmaceutical industry has seen a surge in demand for drugs that treat… Read More

#Exclusive Content

#Biologics #Cell line development #Cell lines #Drug discovery #Proteins

Where do we stand with cell line development?

DDW’s Megan Thomas examines the value and impact of cell line development in the drug discovery industry. When it comes to the creation of biologics, cell line development is an essential drug discovery process. From a functional perspective, when it comes to monoclonal antibodies (mAbs), enzymes, or other therapeutic proteins,… Read More

#Exclusive Content

#Cell line development #Cell lines #Drug discovery #Interview #Tune Therapeutics

Innovating biopharmaceuticals: The benefits of cell line development

DDW’s Megan Thomas speaks to Dr Lucas Thompson, Senior Director of Research at Tune Therapeutics, about the advancements in cell line development and how biotechnologies can enhance the precision and efficiency of therapeutic protein production. MT: What are the benefits cell line development is bringing to biopharmaceutical developers? LT: For… Read More

#Exclusive Content

#Axol Bioscience #Cell lines #iPSC #Mergers and acquisitions #Phenocell #Pluripotent stem cells

iPSC technology provider Axol Bioscience acquires Phenocell

Axol Bioscience has fully acquired Phenocell, though financial terms of the agreement were not disclosed. The acquisition extends Axol’s portfolio of iPSC-derived cell models, adding skin and human retinal iPSC-derived cell lines to its existing neuroscience, pain and touch, and cardiovascular products and services. Read More

#Business & Investment #News

#3D cell culture #Assay development optimisation & technology #Biopharmaceuticals #Cell line development #Cell lines #Cell Science #Guide

DDW Cell Line Development Guide 2024

Download the exclusive Guide and read about: What are the benefits cell line development is bringing to biopharmaceutical developers? What technological advances are helping drive efficiencies in cell line development? How is this process underpinning drug development and why is the market growing? In what ways is cell line development… Read More

#DDW eBooks #DDW Guides

#3D cell culture #Assay development optimisation & technology #Biopharmaceuticals #Cell line development #Cell lines #Cell Science

Advances in cell line development

Reece Armstrong offers an overview of cell line development and outlines the benefits the technology is bringing to biopharmaceutical developers. Cell line development is an essential underpinning of the drug development process, enabling teams to test, optimise and manufacture therapeutics at a commercial scale. It is a crucial for the… Read More

#Exclusive Content

#Cell line development #Cell lines #Drug development

Advancing stability in cell line development 

Roxana McCloskey, Senior Global Marketing Manager, Protein Therapeutics, SCIEX explores how innovative analytical approaches can help improve stability for cell line development.   Cell line development (CLD) is a critical stage in the early production of biotherapeutic molecules. During the CLD stage, a key goal is to… Read More

#Exclusive Content

Two scientists working in a lab
#Antibody discovery workflow #Biotherapeutics #Cell line development #Cell lines #Drug development #Large molecules

Advancements in upstream CLD for enhanced biotherapeutics production

This article is sponsored by Revvity. By Anis H Khimani, PhD, Senior Strategy Leader, Life Sciences strategy group, Revvity, Inc. Across the biotherapeutics workflow The landscape of large molecule drug development has evolved significantly in recent decades. As the significance of large molecules… Read More

#Exclusive Content

#Biopharma #Cell line development #Cell lines #FDA #Genetic diseases #Genetics #R&D

New podcast: Challenges and tactics for drug development

This is the latest episode of the free DDW narrated podcast, “Challenges and tactics for transformative drug development”. It covers two articles written for Volume 23, Issue 2 – Spring 2022 of DDW. They are called “Balancing speed and quality in CLD for faster drug development”, and… Read More

#News

#Biopharmaceuticals #Cell line development #Cell lines #Picodroplet technology #Single cell sorter #Single-cell analysis

Embedding quality into cell line development through the application of an innovative picodroplet-based single cell sorter

Generation of a highly expressing, regulatory acceptable clonal cell line is the first key activity in the development of a biopharmaceutical. Cell line development is labour intensive, time consuming and costly and is subject to stringent regulations to ensure patient safety. Dr Jonathan H Dempsey All cell lines used to… Read More

Webinar date:
Brought to you by Sphere Fluidics
#Webinars

#Cell lines #Manufacturing

KBI Biopharma & Selexis open integrated manufacturing facility  

Contract manufacturing organisation (CMO) KBI Biopharma and cell line development company Selexis have opened an integrated facility in Geneva, Switzerland.  The integrated KBI/Selexis state-of-the-art facility builds upon the companies’ existing market foothold by combining best-in-class cell line development (CLD) and expert mammalian cell manufacturing in a single… Read More

#News

#Cell culture #Cell lines

How cell culture just got smarter

The Olympus Provi CM20 incubation monitoring system can be used to develop methods for efficient quality control and data management within your cell culture workflow. The company has created an application note which will allow you to understand how the quantitative data collected from the CM20 enabled users to compare… Read More

#News